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Abstract
Background: In the present study, we investigated the changes of uptake and efflux transport of taurine under
various stress conditions using rat conditionally immortalized syncytiotrophoblast cell line (TR-TBT cells), as in vitro
blood-placental barrier (BPB) model.
Methods: The transport of taurine in TR-TBT cells were characterized by cellular uptake study using radiolabeled
taurine. The efflux of taurine was measured from the amount of radiolabeled taurine remaining in the cells after
the uptake of radiolabeled taurine for 60 min.
Results: Taurine uptake was significantly decreased by phosphorylation of protein kinase C (PKC) activator in TR-
TBT cells. Also, calcium ion (Ca2+) was involved in taurine transport in TR-TBT cells. Taurine uptake was inhibited
and efflux was enhanced under calcium free conditions in the cells. In addition, oxidative stress induced the
change of taurine transport in TR-TBT cells, but the changes were different depending on the types of oxidative
stress inducing agents. Tumor necrosis factor-a (TNF-a), lipopolysaccharide (LPS) and diethyl maleate (DEM)
significantly increased taurine uptake, but H2O2 and nitric oxide (NO) donor decreased taurine uptake in the cells.
Taurine efflux was down-regulated by TNF-a in TR-TBT cells.
Conclusion: Taurine transport in TR-TBT cells were regulated diversely at extracellular Ca2+ level, PKC activator and
oxidative stress conditions. It suggested that variable stresses affected the taurine supplies from maternal blood to
fetus and taurine level of fetus.
Introduction
Taurine, one of the essential nutrients, exists in high
concentration in most tissues, where it shows various
physiological functions such as including conjugation
with bile acids, anti-oxidation, detoxification, osmoregu-
lation, membrane stabilization and modulation of intra-
cellular calcium level [1-4]. Also, taurine plays an
important role in fetal development because taurine
deficiency during pregnancy is associated with growth
retardation, retinal degeneration and dysfunction of the
central nervous system (CNS) [5,6]. In general, it was
known that taurine can be supplied to most of human
tissues by diet or biosynthesis in human body. However,
although taurine is a pivotal amino acid at fetal and
neonatal stages, the fetus has low capacities to synthe-
size taurine due to deficiency of enzyme, cysteine sulfi-
nate decarboxylase [2]. Thus, taurine has to be supplied
to the fetus from the maternal circulating blood via
placenta.
The placenta regulates transport of nutrients and
exchange of gases between maternal and fetal blood,
and the blood-placenta barrier (BPB), which is com-
posed of syncytiotrophoblast cells, has a key role in
these functions [7]. It already has been reported that
human placental syncytiotrophoblast possesses an active
high-affinity transport system for taurine, the taurine
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transporter (TauT) [8,9]. TauT is dependent on sodium
and chloride ion and is regulated by protein kinase C
(PKC), glucose, hypertonicity and cytokine in various
cells and organs such as brain, retina, intestinal cell and
hepatic cell [2].
In the present study, we focused on the effect of oxi-
dative stress on taurine transport in placenta. It was
known that taurine plays a role as an antioxidant in
the human body. Accordingly, transport activity of
taurine may be also changed at the BPB under the
pathophysiological conditions induced by oxidative
stress, and this change could intensely affect the pro-
tective effect of taurine by influencing taurine concen-
tration in the fetus. In the recent report, it showed
that the level of taurine in the fetus at intrauterine
growth restriction (IUGR) was low [10], NO level was
also high in IUGR pregnancies [11]. It suggests a
mutual relation between oxidative stress and taurine
transport. However, the regulation of taurine transport
at the BPB under oxidative stress remains uncertain at
the present time. Thus, it is necessary to investigate
the effect of oxidative stress on taurine transport in
placenta. Oxidative stress in the cells is induced by
increased oxidant generation, decreasing oxidant pro-
tection and failure of repairing oxidative damage. A
reactive oxygen species (ROS) is generated in vivo by
aerobic respiration, metabolism of xenobiotic com-
pounds and inflammation induced by phagocytosis
process [12]. Therefore, we evaluated the regulation of
taurine transport under various conditions inducing
oxidative stress such as pro-inflammatory cytokine,
tumor necrosis factor-a (TNF-a); bacterial endotoxin,
lipopolysaccharide (LPS); compound inducing a deple-
tion of antioxidant such as glutathione, diethyl maleate
(DEM); a ROS compound, hydrogen peroxide (H2O2);
nitric oxide (NO) donor, 3-morpholinosyndomine
(SIN-1).
Kitano et al. established a conditionally immortalized
rat syncytiotrophoblast cell line, TR-TBT cells, from
pregnant transgenic rat placenta at gestational day 18
[13]. TR-TBT 18d-1 and 18d-2 were originated from the
syncytiotrophoblast I (maternal side) and II (fetal side),
respectively, because rat syncytiotrophoblast consists of
two layers while that of human is composed with one
layer. TR-TBT cells is a good model for the analysis of
the placental transport of nutrients [13,14]. We have




Radiolabeled [3H]taurine (SA 20.1 Ci/mmol) was obtained
from NEN Life Science Products Inc. (Boston, MA).
Tumor necrosis factor-a (TNF-a), lipopolysaccharide
(LPS), 3-morpholinosyndomine (SIN-1), phorbol 12-myr-
istate 13-acetate (PMA), nifedipine, nimodipine, verapamil,
nickel chloride (NiCl2) and cadmium chloride (CdCl2)
were purchased from Sigma Chemical (St. Louis, MO).
Diethyl maleate (DEM) and hydrogen peroxide (H2O2)
was obtained from Aldrich chemical Co. (St. Louis, MO)
and Junsei chemical Co. (Tokyo, Japan), respectively.
Cell culture
The TR-TBT cells were cultured with Dulbecco’s modi-
fied Eagle’s medium (Invitrogen, San Diego, CA), sup-
plemented with 10% fetal bovine serum, 100 U/ml
penicillin, and 100 μg/ml streptomycin (Invitrogen, San
Diego, CA) at 33°C in a humidified atmosphere of 5%
CO2/air. On rat tail collagen type I-coated 24 well cul-
ture plates (IWAKI, Tokyo, Japan) initial seeding was
done at 1×105 cells/well for the uptake study. After
incubation for 3 days at 33°C, the cultures became con-
fluent. Then the cells were incubated at 37°C for a
further 3 days.
Functional studies
The [3H]taurine uptake was performed according to the
previous report [15]. TR-TBT cells were washed three
times with 1 ml extracellular fluid (ECF) buffer consist-
ing of 122 mM NaCl, 25 mM NaHCO3, 3 mM KCl, 1.4
mM CaCl2, 1.2 mM MgSO4, 0.4 mM K2HPO4, 10 mM
D-glucose and 10 mM Hepes (pH 7.4) at 37°C. Uptake
was initiated by applying 200 μL containing [3H]taurine
(28 nM) at 37°C. Under a Ca2+ free condition, Ca2+ was
replaced with Mg2+. [3H]Taurine uptake was stopped by
removing the isotope ECF buffer and washing the cells
with ice ECF buffer three times. To investigate the effect
of phosphorylation of PKC on taurine uptake in TR-
TBT cells, the cells was pre-incubated for 30 min in the
presence of a PKC activator, PMA (1 μM). After that,
[3H]taurine uptake study was performed as described
above. To investigate the change of taurine uptake
under the oxidative stress condition, the TR-TBT cells
were pretreated with 20 ng/mL TNF-a, 10 ng/mL LPS,
100 μM DEM, 2 mM H2O2 or 1 mM SIN-1 for 3, 6, 9,
12 and 24 h, and the uptake study was performed as
described above. The cells were then solubilized by
incubation overnight in 750 µl of 1 N NaOH at RT. An
aliquot (50 µl) was taken for quantification of cellular
protein using a DC protein assay kit (Bio-Rad, Hercules,
CA) with bovine serum albumin as a standard. The
remaining solution (500 µl) was mixed with 5 ml of
scintillation cocktail (Hionic-fluor; Packard, Meriden,
CT) for measurement of radioactivity in a liquid scintil-
lation counter (LS6500; Beckman, Fullerton, CA).
The efflux of [3H]taurine by TR-TBT cells was deter-
mined by incubating the cells for 60 min at 37°C with
[3H]taurine dissolved in ECF buffer. The medium was
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then removed, and the cells were washed with ice-cold
ECF buffer. The incubation medium alone or Ca2+ free
medium was added for desired times. After appropriate
time periods, the incubation medium was removed and
the amount of [3H]taurine remained in the cells was
measured. To induce oxidative stress in the cells, the
TR-TBT cells were pretreated with 20 ng/mL TNF-a,
10 ng/mL LPS and 100 μM DEM for 9 hrs, 9 hrs and
12 hrs, respectively, and the efflux study was performed
as described above.
Data analysis
All data are given as mean ± SEM values. Statistical ana-
lyses were carried out by one-way ANOVA with Dun-
nett’s post-hoc test and p<0.05 was considered
statistically significant.
Results
Effect of protein kinase C (PKC) on the taurine uptake in
TR-TBT cells
Taurine transport was regulated by phosphorylation of
PKC in TR-TBT cells. As exposed to PKC activator,
PMA (1 μM), [3H]taurine uptake was significantly
decreased in TR-TBT cells (Fig. 1).
Effect of Ca2+ and calcium channel blockers on the
taurine transport in TR-TBT cells
We investigated the effect of Ca2+ on taurine transport
in TR-TBT cells by removal of Ca2+ from ECF buffer or
addition of various calcium channel blockers in ECF
buffer. Under Ca2+ free conditions, [3H]taurine uptake
was significantly reduced in TR-TBT cells (Fig. 2). Var-
ious calcium channel blockers such as 0.3 mM verapa-
mil, 2 mM nifedipine, 1 mM NiCl2 and 0.3 mM CdCl2
induced a significant decrease of the [3H]taurine uptake
(Fig. 2). But, [3H]taurine uptake was not changed in the
presence of nimodipine in the cells (Fig. 2). In the pre-
sence of 2.8 mM (2-folds) Ca2+, the [3H]taurine uptake
had no change in TR-TBT 18d-1 cells, and was
increased slightly in TR-TBT 18d-2 cells. The efflux of
[3H]taurine was increased significantly in the cells under
Ca2+ depletion condition (Table 1).
Effect of oxidative stress on the taurine transport in TR-
TBT cells
We investigated a change of the taurine uptake and
efflux under oxidative stress conditions in TR-TBT cells.
To induce various oxidative stress conditions, the cells
were incubated in TNF-a (20 ng/mL), LPS (10 ng/mL),
DEM (100 μM), H2O2 (2 mM) and SIN-1 (1 mM) for 3,
6, 9, 12 and 24 hrs. [3H]Taurine uptake was significantly
increased by pre-treatment with TNF-a (20 ng/mL),
LPS (10 ng/mL) and DEM (100 μM) for 24 hrs in the
cells (Table 2). Whereas, as exposed to 2 mM H2O2 and
Figure 1 Inhibition of [3H]taurine uptake by PKC activator in
TR-TBT cells. After 30 min pre-treatment of protein kinase C
activator, phorbol 12-myristate 13-acetate (PMA), [3H]taurine (28 nM)
uptake study was performed at 37°C for 5 min in TR-TBT 18d-1 cells
(open bar) and TR-TBT 18d-2 cells (shaded bar). Each value
represents the mean ± SEM (n=3). * p<0.05, ** p<0.01 significantly
different from control.
Figure 2 Effect of Ca2+ and calcium channel blockers on [3H]
taurine uptake by TR-TBT cells. [3H]Taurine (28 nM) uptake was
performed at 37°C for 5 min in ECF buffer in the absence or the
presence of 2.8 mM calcium ion, 1 mM nickel chloride, 0.3 mM
cadmium chloride, 0.3 mM verapamil, 2 mM nifedipine and 2 mM
nimodipine in TR-TBT 18d-1 cells (open bar) and TR-TBT 18d-2 cells
(shaded bar). Under Ca2+ free condition, Ca2+ was replaced Mg2+.
Each value represents the mean ± SEM (n=3-4). * p<0.05, ** p<0.01
significantly different control.
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1 mM SIN-1 for 24 hrs in the cells, [3H]taurine uptake
was significantly decreased (Table 2).
The effect of TNF-a, LPS and DEM pre-treatment on
[3H]taurine efflux was also examined in TR-TBT cells.
Fig. 3 showed the effect of TNF-a, LPS and DEM pre-
treatment on the [3H]taurine efflux for the designated
time. LPS and DEM pre-treatment did not affect [3H]
taurine efflux significantly, but TNF-a treatment inhib-
ited [3H]taurine efflux significantly in the cells (Fig. 3).
Discussion
In the present study, we investigated the change of taur-
ine transport via the placenta under various stress con-
ditions using TR-TBT cells. It was reported that taurine
transporter (TauT) existed in human placenta [8] and
also the presence of TauT in TR-TBT cells was identi-
fied [14]. We also identified the characteristics of TauT
which were previously known in various cells and
organs such as brain, retina and intestinal cell [2] from
the results (data not shown). The taurine uptake had
time and sodium and chloride ion dependency and sub-
strate specificity in TR-TBT cells. [3H]Taurine uptake
was decreased significantly under extracellular calcium
depletion (Fig. 2). The taurine uptake had calcium ion
dependency as well as sodium and chloride ion, and it
was sensitive to calcium depletion in extracellur fluid
than calcium abundance (Fig. 2). In addition, the taurine
efflux was evoked under calcium free condition about
20% over control (Table 1). These results suggested that
an increase of taurine efflux might contribute to a
decrease of taurine uptake at calcium free condition.
Also, Na+-Ca2+ exchanger is associated with these
effects of Ca2+ on taurine transport [4]. A change of
Ca2+ concentration at intracellular or extracellular envir-
onment induced a change of Na+ concentration, and it
may affect taurine transport by the cells because taurine
transporter is very sensitive to Na+ concentration. Also,
it was reported that Ca2+ free medium enhanced the
taurine efflux in the rat striatum in vivo [17]. According
to this study, the mechanism of an increase of taurine
efflux by calcium depletion was considered that
decreased calcium influx and increased nonspecific
influx of Na+ into the cells induced an increase of taur-
ine efflux [17]. Therefore, the decrease of taurine uptake
under calcium depletion may be related with the
increase of taurine efflux through the change of concen-
tration of Na+ in the cells.
Taurine acts as an antioxidant, and has protection
function when cell is damaged by oxidative stress [2].
This study showed that taurine uptake was increased
under oxidative stress conditions for 24 hrs, TNF-a,
LPS and DEM, respectively pro-inflammatory cytokine,
bacterial endotoxin and a compound inducing oxidative
stress by depleting of glutathione levels (Table 2). It was
reported that mRNA level of TauT and taurine uptake
by the cells was increased in brain capillary endothelial
Table 2 Effect of oxidative stress inducing agents on [3H]
taurine uptake in TR-TBT cells
Pretreatment [3H]Taurine uptake (% of control)
Compounds TR-TBT 18d-1 TR-TBT 18d-2
Control 100 ± 7 100 ± 14
TNF- a 20 ng/mL 139 ± 11 * 150 ± 12 **
LPS 10 ng/mL 124 ± 4 ** 128 ± 7 *
DEM 100 μM 137 ± 16 ** 154 ± 11 **
H2O2 2 mM 85.2 ± 1.8
** 79.8 ± 3.2 **
SIN-1 1 mM 66.8 ± 2.2 ** 84.2 ± 3.8 *
Cells were treated with tumor necrosis factor-a (TNF- a, 20 ng/mL),
lipopolysaccharide (LPS, 10 ng/mL), diethyl maleate (DEM, 100 μM), hydrogen
peroxide (H2O2, 2 mM) and 3-morpholinosyndomine (SIN-1, 1 mM) for 24 hrs,
respectively. [3H]Taurine (28 nM) uptake was performed at 37°C for 5 min.
Each value represents the mean ± SEM (n=3-4). *p<0.05, ** p<0.01 significantly
different from the control.
Figure 3 Effect of oxidative stress inducing agents on [3H]
taurine efflux by TR-TBT cells. Cells were pre-treated with several
stimulants for the specific time showed maximal taurine uptake,
TNF-a (20 ng/mL) for 9 hrs, LPS (10 ng/mL) for 9 hrs and DEM (100
μM) for 12 hrs, respectively and then [3H]taurine efflux was
examined in TR-TBT 18d-1 (open bar) cells and TR-TBT 18d-2 cells
(shaded bar). Each value represents the mean ± SEM (n=3). * p <
0.05, significantly different from control.
Table 1 Effect of calcium ion on [3H]taurine efflux in TR-
TBT cells
Condition Intracellular amount of [3H]taurine remained (% of
time 0)
TR-TBT 18d-1 TR-TBT 18d-2
Control 100 ± 2 100 ± 3
Ca2+ free 72.1 ± 3.3 ** 75.7 ± 4.5 **
Cells were incubated for 60 min at 37°C with ECF buffer containing [3H]
taurine (28 nM). The cells were washed and then incubated with ECF buffer or
Ca2+ free buffer for 30 min Under Ca2+ free condition, Ca2+ was replaced with
Mg2+. Remaining of [3H]taurine in the cells was measured. Each value
represents the mean ± SEM (n=3-4). ** p<0.01 significantly different from
normal efflux.
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cells [18], astrocytes [19] and intestinal cells [16] by pre-
treatment of TNF-a. The TNF-a signal is known to
activate nuclear factor-B (NF-B) transcriptional activ-
ity by nuclear translocation [20]. Also, the NF-B bind-
ing site is found in the TauT promoter region [20].
Therefore, it suggested that the TNF-a-NF-B pathway
could be associated in TauT up-regulation. DEM
induced oxidative stress through the depletion of intra-
cellular glutathione (GSH) [21] and up-regulated the
cystine uptake in the organ [22]. Taurine is also sulfur-
containing amino acid like cystine, therefore, it seems
that DEM may induce an increase of taurine uptake in
TR-TBT cells. It was reported that LPS reduced taurine
uptake significantly in macrophage cell lines and Caco2
cells [23-25], had no effect in conditionally immortalized
brain microvascular endothelial cells [18]. In macro-
phage cell line, it was explained that LPS decreased
taurine uptake might be via the action of nitric oxide
[23]. In the present study, LPS increased taurine uptake
slightly in TR-TBT cells, and it is contrary to previous
results. It is known that LPS stimulates production of
many kinds of cytokines such as TNF-a. Therefore, it
may be possible that taurine uptake was increased by
TNF-a stimulated by LPS. Also, under hypertonic con-
ditions, LPS activates taurine transport [24]. It is possi-
ble therefore to speculate that a switch controls the
direction of LPS effect, but the complexity of the signal-
ing pathways makes it very difficult [25]. The mechan-
ism study of changes of taurine transport by LPS is
needed to be further elucidated.
On the other hand, treatment of hydrogen peroxide
induced reduction of taurine uptake (Table 2). Meng
and colleagues showed that hydrogen peroxide elevated
the phosphorylation of tyrosine residues via inhibition of
tyrosine phosphatase [26]. Several of the serines, threo-
nines and tyrosines in the intracellular domains of TauT
are situated in motifs highly suitable as targets for pro-
tein kinases. In general, TauT is regulated by protein
kinase C (PKC) phosphorylation of Ser-322, so activa-
tion of PKC inhibits taurine transport [2,3]. It was
reported that there is possibility that a shift of TauT to
a more tyrosine phosphorylated state in congruence
with increased serine/threonine phosphorylation of
TauT reduces the active taurine uptake following expo-
sure to hydrogen peroxide [27]. We also identified that
taurine uptake was inhibited by activator of PKC, PMA
in TR-TBT cells (Fig. 1). It has been known that PMA
activates Ca2+ dependent and Ca2+ independent PKCs
[28]. Accordingly, an increased phosphorylation of TauT
could be involved in H2O2-induced reduction of taurine
uptake in TR-TBT cells.
Exposing the cells to nitric oxide donor induced a
reduction of taurine uptake significantly in TR-TBT
cells (Table 2). NO donor, SIN-1, releases NO, O2
- and
ONOO-. It was demonstrated that ONOO- interacted
with TauT tyrosine residues and formation of nitrotyro-
sine was detected highly in NO donor treatment
[29-32]. These alterations of transporter induced a
reduction of taurine transport activity. In pregnant
women having intrauterine growth restriction (IUGR)
disease, placental transport capacity of taurine was
reduced and fetal taurine level was decreased [33]. In
addition, it has been previously shown that IUGR is
associated with increased fetoplacental NO levels [12].
Thus, NO could play an important role in down-regu-
lating TauT activity in IUGR.
Taurine efflux in TR-TBT cells was examined by mea-
suring the remaining intracellular taurine. Our results
showed that [3H]taurine efflux was significantly
decreased by TNF-a pre-treatment, but had no change
by LPS and DEM (Fig. 3). These results coincided with
previous in vivo study in rat brain [34]. Thus, oxidative
stress condition affected taurine efflux in TR-TBT cells
as well as taurine uptake. Also, these results suggested
that decrease of taurine efflux by TNF-a may be a possi-
ble mechanism for increase of taurine uptake to the cells.
Conclusions
1. Taurine transport was regulated by PKC in TR-
TBT cells. Also, Ca2+ was involved in taurine trans-
port, and Ca2+ free conditions decreased taurine
uptake and evoked taurine efflux.
2. Oxidative stress induced the change of taurine
transport in TR-TBT cells, but the change was dif-
ferent as a type of oxidative stress inducing agents.
Taurine uptake was increased by TNF-a, LPS and
DEM pre-treatment, but decreased by H2O2 and NO
stimulation. Whereas, taurine efflux was only regu-
lated by TNF-a pre-treatment.
3. The taurine transport through the BPB was regu-
lated in various stress conditions, and these results
suggest that variable stresses affect the taurine sup-
plies from maternal blood to fetus and taurine level
of fetus.
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